Immunology Biotech Companies and Upcoming Catalysts

Public company snapshots and catalyst previews organized by sector.

Public Company List

Ticker	Company	Lead Asset	Indication	Stage	Next Catalyst
GNPX	Genprex Inc	COVID-19	pulmonary inflammation triggered by COVID-19	Approved	2028-03

Company	Ticker	Catalyst	Timing	Asset	Confidence
Curis Inc	CRIS	Corporate Update	October 2015	CA-170	Low
Genprex Inc	GNPX	Enrollment Update	Dec 2020	COVID-19	Low